Cargando…
ALAD Inhibition by Porphobilinogen Rationalizes the Accumulation of δ-Aminolevulinate in Acute Porphyrias
[Image: see text] Patients with major forms of acute hepatic porphyria present acute neurological attacks with overproduction of porphobilinogen (PBG) and δ-aminolevulinic acid (ALA). Even if ALA is considered the most likely agent inducing the acute symptoms, the mechanism of its accumulation has n...
Autores principales: | San Juan, Itxaso, Pereira-Ortuzar, Tania, Cendoya, Xabier, Laín, Ana, To-Figueras, Jordi, Mateos, Borja, Planes, Francisco J., Bernardo-Seisdedos, Ganeko, Mato, José M., Millet, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631992/ https://www.ncbi.nlm.nih.gov/pubmed/36241173 http://dx.doi.org/10.1021/acs.biochem.2c00434 |
Ejemplares similares
-
Normal reference ranges for urinary δ‐aminolevulinic acid and porphobilinogen levels
por: Agarwal, Sagar, et al.
Publicado: (2020) -
Role of δ-Aminolevulinic Acid Dehydratase (ALAD) gene polymorphism in lead induced nephrotoxicity
por: Tiwari, Mugdha, et al.
Publicado: (2014) -
Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria
por: Bernardo-Seisdedos, Ganeko, et al.
Publicado: (2021) -
Case Report: Lack of Response to Givosiran in a Case of ALAD Porphyria
por: Graff, Erica, et al.
Publicado: (2022) -
Derivative Matrix-Isopotential Synchronous Spectrofluorimetry and Hantzsch Reaction: A Direct Route to Simultaneous Determination of Urinary δ-Aminolevulinic Acid and Porphobilinogen
por: Ajmal, Muhammad, et al.
Publicado: (2022)